HCPCS Level IIdrugActive
J9394
Inj, fulvestrant (fresenius)
BETOS: O1E
Effective: 2023-01-01
Description
Injection, fulvestrant (fresenius kabi) not therapeutically equivalent to j9395, 25 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Fulvestrant
Manufacturer
FreseniUS Kabi USA, LLC
HCPCS Dosage
25 MG
Billing Units
10.0000
1
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.